Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction / De Angelis, A; Cappetta, D; Piegari, E; Rinaldi, B; Ciuffreda, Lp; Esposito, G; Ferraiolo, Fav; Rivellino, A; Russo, R; Donniacuo, M; Rossi, F; Urbanek, K; Berrino, ; L,. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - (2016). [10.1016/j.ijcard.2016.04.168]

Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction

Urbanek K;
2016

2016
Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction / De Angelis, A; Cappetta, D; Piegari, E; Rinaldi, B; Ciuffreda, Lp; Esposito, G; Ferraiolo, Fav; Rivellino, A; Russo, R; Donniacuo, M; Rossi, F; Urbanek, K; Berrino, ; L,. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - (2016). [10.1016/j.ijcard.2016.04.168]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/885135
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 29
social impact